| 000 | 01524 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518033740.0 | ||
| 264 | 0 | _c20200413 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1744-5078 | ||
| 024 | 7 |
_a10.1080/09273948.2019.1582786 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJain, Sahil | |
| 245 | 0 | 0 |
_aResolution of Large Choroidal Tuberculoma following Monotherapy with Intravitreal Ranibizumab. _h[electronic resource] |
| 260 |
_bOcular immunology and inflammation _cApr 2020 |
||
| 300 |
_a494-497 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aChoroid _xdiagnostic imaging |
| 650 | 0 | 4 |
_aChoroid Diseases _xdiagnosis |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFundus Oculi |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xisolation & purification |
| 650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 |
_aTuberculoma _xdiagnosis |
| 650 | 0 | 4 |
_aTuberculosis, Ocular _xdiagnosis |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aVisual Acuity |
| 700 | 1 | _aAgarwal, Aniruddha | |
| 700 | 1 | _aGupta, Vishali | |
| 773 | 0 |
_tOcular immunology and inflammation _gvol. 28 _gno. 3 _gp. 494-497 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/09273948.2019.1582786 _zAvailable from publisher's website |
| 999 |
_c29589712 _d29589712 |
||